Filana Therapeutics, Inc. — Revenue by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/38ad9aef-a446-4cb5-b340-e0883651dd20/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2013 | $41.1M | 2013-01-01 – 2013-12-31 | evidence 0001069530-14-000004 |
| FY 2012 | $10.9M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-046147 |
| FY 2011 | $11.5M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-049361 |
| FY 2010 | $16.8M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-049361 |
| FY 2009 | $20.6M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-049361 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Filana Therapeutics, Inc. — all facts · Net Income · Operating Income